Determining the effect of ellagic acid on the proliferation and migration of pancreatic cancer cell lines

@article{Kim2021DeterminingTE,
  title={Determining the effect of ellagic acid on the proliferation and migration of pancreatic cancer cell lines},
  author={Ji Yoon Kim and Yun Ju Choi and Ha-Jeong Kim},
  journal={Translational Cancer Research},
  year={2021},
  volume={10},
  pages={424 - 433}
}
Background Ellagic acid is a natural dietary compound found in several berries and fruits. It inhibits fibrosis, inflammation and carcinogenesis. We tried to find out what role ellagic acid plays in pancreatic cancer to see if it can be used as an adjuvant for chemotherapy. Methods Three pancreatic cancer cell lines, PANC-1, AsPC-1, and MIA PaCA-2, were used. Cell growth was measured by MTT assay. Activities of caspase-3 and caspase-8, and caspase-9 were evaluated to determine the apoptosis… 
1 Citations

Figures and Tables from this paper

Ellagic acid: insight into its protective effects in age-associated disorders

The present review focuses on the protective effect of ellagic acid in age-associated disorders, and the scope of this review is limited to cancer, diabetes, cardiovascular and neurodegenerative disorders.

References

SHOWING 1-10 OF 29 REFERENCES

The Inhibitory Effect of Ellagic Acid on Cell Growth of Ovarian Carcinoma Cells

The results indicated that EA is a potential novel chemoprevention and treatment assistant agent for human ovarian carcinoma.

Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo

It is demonstrated that EA inhibited cell growth, cell repairing activity, cell migration and invasion in a dose-dependent manner, and effectively inhibit human pancreatic cancer growth in mice.

Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells.

The data indicate that ellagic acid stimulates apoptosis through inhibition of the prosurvival transcription factor NF-kappa B via the mitochondrial pathway of apoptosis associated with mitochondrial depolarization, cytochrome C release, and the downstream caspase activation.

Ellagic acid exerts anti-proliferation effects via modulation of Tgf-β/Smad3 signaling in MCF-7 breast cancer cells.

Ellagic acid leads to decreased phosphorylation of RB proteins mainly through modulation of the TGF-β/Smad3 pathway, and thereby inhibits the proliferation of MCF-7 breast cancer cells.

Ellagic Acid Normalizes Mitochondrial Outer Membrane Permeabilization and Attenuates Inflammation-Mediated Cell Proliferation in Experimental Liver Cancer

The value of molecular approaches is demonstrated in identifying the potential role of EA as an effective chemopreventive agent against experimental liver cancer in rats and transmission electron microscopy analysis of the livers of experimental rats demonstrated that EA treatment renovated its internal architecture.

Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection.

Antioxidant and apoptosis-inducing activities of ellagic acid.

Ellagic acid exhibited both antioxidant activity in V79-4 cells and apoptosis-inducing activity in HOS cells through the up-regulation of Bax and activation of caspase-3.

Effect of Ellagic Acid, a Plant Polyphenol, on Fibrotic Markers (MMPs and TIMPs) during Alcohol-Induced Hepatotoxicity

It is suggested that Ellagic acid at the dosage of 60 mg/kg body weight effectively decreased the expression pattern of fibrotic markers during alcohol-induced toxicity and can be developed as an antifibrotic compound in near future.

Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis

These results identify an intact proapoptotic pathway in pancreatic cancer cells and suggest that IRF-1 and/or procaspase-1 may represent potential therapeutic targets to be further explored.